Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
University of Michigan Rogel Cancer Center
Thomas Jefferson University
Mayo Clinic
OHSU Knight Cancer Institute
City of Hope Medical Center
OHSU Knight Cancer Institute
Mayo Clinic
Emory University
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
NRG Oncology
M.D. Anderson Cancer Center
Mayo Clinic
Mayo Clinic
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Emory University
Mayo Clinic
Mayo Clinic
Jonsson Comprehensive Cancer Center
NRG Oncology
City of Hope Medical Center
University of California, San Francisco
Mayo Clinic
Vanderbilt-Ingram Cancer Center
Stanford University
Copernicus Memorial Hospital
University of Southern California
M.D. Anderson Cancer Center
Assistance Publique - Hôpitaux de Paris
Northwestern University
Nottingham University Hospitals NHS Trust
Albert Einstein College of Medicine
Emory University
M.D. Anderson Cancer Center
University of Nottingham
Massachusetts General Hospital
Memorial Sloan Kettering Cancer Center
Lund University Hospital
Massachusetts General Hospital
University of Washington
University of Wisconsin, Madison
University of Pittsburgh
University of Washington
British Columbia Cancer Agency